![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07D 231/56 | |
C07D 295/185 | |||
A61K 31/445 | |||
C07D 471/04 |
(11) | Number of the document | 3458445 |
(13) | Kind of document | T |
(96) | European patent application number | 17800088.1 |
Date of filing the European patent application | 2017-05-17 | |
(97) | Date of publication of the European application | 2019-03-27 |
(45) | Date of publication and mention of the grant of the patent | 2021-02-17 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2017/033099 |
Date | 2017-05-17 |
(87) | Number | WO 2017/201161 |
Date | 2017-11-23 |
(30) | Number | Date | Country code |
201662338116 P | 2016-05-18 | US | |
201762444614 P | 2017-01-10 | US |
(72) |
FISCHER, John, P., US
FELL, Jay, Bradford, US
BLAKE, James, F., US
HINKLIN, Ronald, Jay, US
MEJIA, Macedonio, J., US
HICKEN, Erik, James, US
CHICARELLI, Mark, Joseph, US
GAUDINO, John, J., US
VIGERS, Guy, P.A., US
BURGESS, Laurence, E., US
MARX, Matthew, Arnold, US
CHRISTENSEN, James, Gail, US
LEE, Matthew, Randolf, US
SAVECHENKOV, Pavel, US
ZECCA, Henry, J., US
TANG, Tony, P., US
|
(73) |
Array Biopharma, Inc.,
3200 Walnut Street, Boulder, CO 80301,
US
Mirati Therapeutics, Inc., 9393 Towne Centre Drive Suite 200, San Diego, CA 92121, US |
(54) | KRAS G12C INHIBITORS |
KRAS G12C INHIBITORS |